Janet Ferguson
University of Bath
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Janet Ferguson.
Addiction | 2009
Linda Bauld; John Chesterman; Janet Ferguson; Kenneth Judge
AIM To compare the characteristics and outcomes of users accessing pharmacy and group-based smoking treatment. DESIGN Observational study of administrative information linked with survey data. SETTING Glasgow, Scotland. PARTICIPANTS A total of 1785 service users who set a quit date between March and May 2007. INTERVENTION Smoking treatment services based in pharmacies providing one-to-one support, and in the community offering group support. MEASUREMENTS Routine monitoring data included information about basic demographic characteristics, deprivation category of residence, nature of intervention and smoking status at 4-week follow-up determined by carbon monoxide (CO) readings < or = 10. These data were supplemented by information about socio-economic status and smoking-related behaviours obtained from consenting service recipients by treatment advisers. FINDINGS In the pharmacy-based service 18.6 % of users (n = 1374) were CO-validated as a quitter at 4 weeks, compared with 35.5 % (n = 411) in the group-based service. In a multivariate model, restricted to participants (n = 1366) with data allowing adjustment for socio-demographic and behavioural characteristics and including interaction terms, users who accessed the group-based services were almost twice as likely (odds ratio 1.980; confidence interval 1.50-2.62) as those who used pharmacy-based support to have quit smoking at 4-week follow-up. CONCLUSIONS Specialist-led group-based services appear to have higher quit rates than one-to-one services provided by pharmacies but the pharmacy services treat many more smokers. More research is needed to determine what can be done to bring the success rates of pharmacy services up to those of specialist-led groups and how to expand access to group-based services.
BMJ | 2012
Janet Ferguson; Graeme Docherty; Linda Bauld; Sarah Lewis; Paula Lorgelly; Kathleen A Boyd; Andy McEwen; Tim Coleman
Objective To compare the effects of free nicotine replacement therapy or proactive telephone counselling in addition to standard smoking cessation support offered through a telephone quitline. Design Parallel group, 2×2 factorial, randomised controlled trial. Setting National quitline, England. Participants 2591 non-pregnant smokers aged 16 or more residing in England who called the quitline between February 2009 and February 2010 and agreed to set a quit date: 648 were each randomised to standard support, proactive support, or proactive support with nicotine replacement therapy, and 647 were randomised to standard support with nicotine replacement therapy. Interventions Two interventions were offered in addition to standard support: six weeks’ nicotine replacement therapy, provided free, and proactive counselling sessions (repeat telephone calls from, and interaction with, cessation advisors). Main outcome measures The primary outcome was self reported smoking cessation for six or more months after the quit date. The secondary outcome was cessation validated by exhaled carbon monoxide measured at six or more months. Results At six months, 17.7% (n=229) of those offered nicotine replacement therapy reported smoking cessation compared with 20.1% (n=261) not offered such therapy (odds ratio 0.85, 95% confidence interval 0.70 to 1.04), and 18.2% (n=236) offered proactive counselling reported smoking cessation compared with 19.6% (n=254) offered standard support (0.91, 0.75 to 1.11). Data validated by carbon monoxide readings changed the findings for nicotine replacement therapy only, with smoking cessation validated in 6.6% (85/1295) of those offered nicotine replacement therapy compared with 9.4% (122/1296) not offered such therapy (0.67, 0.50 to 0.90). Conclusions Offering free nicotine replacement therapy or additional (proactive) counselling to standard helpline support had no additional effect on smoking cessation. Trial registration ClinicalTrials.gov NCT00775944.
Addiction | 2012
Linda Bauld; Janet Ferguson; Andy McEwen; Rosemary Hiscock
AIMS To assess longer-term outcomes of a drop-in rolling-group model of behavioural support for smoking cessation and the factors that influence cessation outcomes. DESIGN Prospective observational cohort study. SETTING Fag Ends NHS Stop Smoking Service in Liverpool and Knowsley, UK. PARTICIPANTS A total of 2585 clients, aged 16 or over, setting a quit date. MEASUREMENTS Routine monitoring data were collected from Fag Ends service users and were supplemented by survey data on socio-economic circumstances, smoking-related behaviour and self-report and carbon monoxide (CO)-validated smoking status at 52-week follow-up. FINDINGS The CO-validated prolonged abstinence rate at 52 weeks for smokers attending the groups was 5.6%, compared with 30.7% at 4 weeks (a relapse rate of 78.2%). The sample was particularly disadvantaged: 68% resided in the most deprived decile of the English Index of Multiple Deprivation. Higher socio-economic status within the sample was a predictor of quitting. Other predictors of long-term cessation in multivariate analysis included older age, being female, lower levels of nicotine dependence, having a live-in partner, stronger determination to quit and use of varenicline versus other medication. CONCLUSIONS A wholly state-reimbursed clinical stop-smoking service providing behavioural support and medication in a region of high economic and social disadvantage has reached a significant proportion of the smoking population. Long-term success rates are lower than are found typically in clinical trials, but higher than would be expected if the smokers were to try and quit unaided. Research is needed into how to improve on the success rates achieved.
Trials | 2009
Tim Coleman; Andy McEwen; Linda Bauld; Janet Ferguson; Paula Lorgelly; Sarah Lewis
BackgroundTelephone quit lines are accessible to many smokers and are used to engage motivated smokers to make quit attempts. Smoking cessation counselling provided via telephone can either be reactive (i.e. primarily involving the provision of evidence-based information), or proactive (i.e. primarily involving repeated, sequenced calls from and interaction with trained cessation counsellors). Some studies have found proactive telephone counselling more effective and this trial will investigate whether or not proactive telephone support for smoking cessation, delivered through the National Health Service (NHS) Smoking Helpline is more effective or cost-effective than reactive support. It will also investigate whether or not providing nicotine replacement therapy (NRT), in addition to telephone counselling, has an adjunctive impact on smoking cessation rates and whether or not this is cost effective.MethodsThis will be a parallel group, factorial design RCT, conducted through the English national NHS Smoking Helpline which is run from headquarters in Glasgow. Participants will be smokers who call the helpline from any location in England and who wish to stop smoking. If 644 participants are recruited to four equally-sized trial groups (total sample size = 2576), the trial will have 90% power for detecting a treatment effect (Odds Ratio) of 1.5 for each of the two interventions: i) proactive versus reactive support and ii) the offer of NRT versus no offer. The primary outcome measure for the study is self-reported, prolonged abstinence from smoking for at least six months following an agreed quit date. A concurrent health economic evaluation will investigate the cost effectiveness of the two interventions when delivered via a telephone helpline.DiscussionThe PORTSSS trial will provide high quality evidence to determine the most appropriate kind of counselling which should be provided via the NHS Smoking Helpline and also whether or not an additional offer of cost-free NRT is effective and cost effective for smoking cessation.Trial Registration(clinicaltrials.gov): NCT00775944
Mental Health Review Journal | 2007
Linda Bauld; Janet Ferguson; Ann Kerr; Kerry McKenzie; Ann McNeill
Scotlands smoke‐free legislation, introduced in March 2006, included an exemption for psychiatric hospitals. However, following the successful implementation of smoke‐free laws in almost all other workplaces in Scotland, important questions have been raised about why mental health facilities should be excluded. This study aimed to explore a move towards mental health settings becoming smoke‐free in Scotland by reviewing relevant literature, seeking the views of stakeholders and examining a number of case study hospitals who had recently or were in the process of going smoke‐free. The study found that stakeholders were overwhelmingly in favour of moving towards smoke‐free environments. Allowing smoking to continue in these settings when almost all other workplaces are smoke‐free was perceived as reinforcing the stigma attached to mental health, exacerbating inequalities in health, damaging the health of mental health professionals and potentially contributing to staff recruitment problems. Evidence from t...
Addiction | 2005
Janet Ferguson; Linda Bauld; John Chesterman; Ken Judge
Addiction | 2005
Ken Judge; Linda Bauld; John Chesterman; Janet Ferguson
Addiction | 2005
John Chesterman; Ken Judge; Linda Bauld; Janet Ferguson
Nicotine & Tobacco Research | 2011
Linda Bauld; Kathleen A Boyd; Andrew Briggs; John Chesterman; Janet Ferguson; Ken Judge; Rosemary Hiscock
Addiction | 2005
Elspeth Pound; Tim Coleman; Catherine Adams; Linda Bauld; Janet Ferguson